SK Bioscience wins W300b policy funding for pneumococcal vaccine
--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-05-29 15:32 UTC+10:00
Section: All News
Factuality Score: 100
Opinion Category: Neutral
Topics: Politics, Health, Education, Law & Courts, World News, Crime & Justice
--------------------------------------------------------------------
Snippet:
SK Bioscience plans to expedite the late-stage clinical trial of its pneumococcus vaccine by leveraging a 300 billion won ($200 million) government fund.
--------------------------------------------------------------------